Schlichte Megan J, Guidry Jacqueline
Baylor College of Medicine, 1 Baylor Plaza, Houston, TX 77030, USA.
Center for Clinical Studies, 6655 Travis St #120, Houston, TX 77030, USA.
J Clin Med. 2015 May 7;4(5):918-32. doi: 10.3390/jcm4050918.
A formidable threat to the health of women, cervical carcinoma can be prevented in many cases with adequate screening. The current guidelines for cervical carcinoma screening were created as joint recommendations of the American Cancer Society (ACS), the American Society for Colposcopy and Cervical Pathology (ASCCP) and the American Society for Clinical Pathology (ASCP) in 2012, and later accepted and promoted by the American Congress of Obstetricians and Gynecologists (ACOG). The 2012 recommendations underscore the utility of molecular testing as an adjunct to cytology screening for certain women and provide guidance to clinicians based on different risk-benefit considerations for different ages. This manuscript will review screening techniques and current recommendations for cervical cancer screening and human papilloma virus (HPV) testing, as well as possible future screening strategies.
宫颈癌是对女性健康的一大威胁，但在许多情况下，通过充分的筛查可以预防。当前的宫颈癌筛查指南是由美国癌症协会（ACS）、美国阴道镜及宫颈病理学会（ASCCP）和美国临床病理学会（ASCP）于2012年联合发布的建议，后来被美国妇产科医师学会（ACOG）接受并推广。2012年的建议强调了分子检测作为某些女性细胞学筛查辅助手段的实用性，并根据不同年龄的不同风险效益考虑为临床医生提供指导。本文将回顾宫颈癌筛查和人乳头瘤病毒（HPV）检测的筛查技术及当前建议，以及可能的未来筛查策略。
